The Great Reshoring Debate Post-COVID
Sponsored by:
To industry players, the COVID-19 pandemic served as a wake-up call that exposed weaknesses in pharmaceutical supply chains and led to alarming shortages of essential medicines.
Keep up with the top pharma business news of the week. On the go.
Sponsored by: